Steven Z Pavletic MD

Hematologic Oncology

Physician

10 Center DrBethesda, MD 20892
Phone+1 301-402-4899

Dr. Pavletic is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pavletic's full profile Already have an account?

Education & Training

University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1992 - 1995
University of Zagreb Faculty of MedicineClass of 1979

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NE State Medical License 1993 - 2026

Clinical Trials

Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease Start of enrollment: 2004 Oct 26
RECRUITING
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System Start of enrollment: 2007 Oct 30
COMPLETED
PHASE1, PHASE2
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders Start of enrollment: 2009 Aug 25
TERMINATED
PHASE1

Publications & Presentations

PubMed

Baricitinib for refractory chronic graft-versus-host disease: results of a phase 1/2 study.
Noa G Holtzman, Annie Im, Lauren Curtis, Eduard Schulz, Rubina Sharma
Blood Advances. 2026-09-08
Elevated plasma anandamide levels in sclerotic chronic graft-versus-host disease highlight the endocannabinoid system as a potential therapeutic target.
Sencer Goklemez, Steven Z Pavletic, Hyoyoung Choo-Wosoba, Filip Pirsl, Edward W Cowen
Bone Marrow Transplantation. 2026-08-08
Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development.
Joseph A Pidala, Betty K Hamilton, George Liwei Chen, Lynn Onstad, Steven Z Pavletic
Blood Advances. 2026-07-22

Journal Articles

Impact of the 2014 NIH Chronic Graft-Versus-Host Disease Scoring Criteria Modifications Assessed in a Large Cohort of Severely Affected Patients
Lauren M Curtis, Galen O Joe, Jacqueline W Mays, Ann Berger, Pamela Stratton, Ronald E Gress, Sandra A Mitchell, Steven Z Pavletic, Kristin Baird, Nature
The eGVHD App Has the Potential to Improve the Accuracy of Graft Versus Host Disease Assessment: A Multicenter Randomized Controlled Trial
Annie Im, Steven Z Pavletic, Haematologica

Abstracts/Posters

Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic Malignancy
Steven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)
Steven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Clinical Characterization and Cytokine Profile of Fatigue in Patients with Chronic Gvhd
Steven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Q&A with Director of the NIH Dermatology Consultation ServiceDecember 24th, 2024
GVHD Alliance to Honor Steven Pavletic with the Inaugural Lukas D. Wartman GVHD Achievement AwardFebruary 16th, 2023
The Future of Chronic Graft-Versus-Host DiseaseFebruary 1st, 2021